HEATHER RAKESH SHAH MD NPI 1093767493

NPI Details

Heather Rakesh Shah, MD is a hematology and oncology internal medicine in Decatur, AL with 23 years of experience. The provider is an internist doctor of osteopathy that specializes in the treatment of the combination of hematology and oncology disorders. A doctor of osteopathy that is board eligible/certified by the American Osteopathic Board of Internal Medicine WAS able to obtain a Certificate of Special Qualifications in the field of Hematology and Oncology. The Certificate is NO longer offered. Heather Rakesh Shah, MD NPI is 1093767493. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a female.

Education
Medical School: UNIVERSITY OF ALABAMA SCHOOL OF MEDICINE
Graduation Year:2003

The provider's business location address is:

1107 14TH AVE SE STE 200
DECATUR, AL
ZIP 35601-354
Phone: (256) 705-4224
Fax: (256) 705-4135

The NPI 1093767493 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, levoleucovorin (khapzory), 0.5 mg (HCPCS:J0642)
• Injection, denosumab, 1 mg (HCPCS:J0897)
• Injection, darbepoetin alfa, 1 microgram (non-esrd use) (HCPCS:J0881)
• Injection, pembrolizumab, 1 mg (HCPCS:J9271)
• Injection, ferric carboxymaltose, 1 mg (HCPCS:J1439)
• Injection, paclitaxel, 1 mg (HCPCS:J9267)
• Injection, ferric derisomaltose, 10 mg (HCPCS:J1437)
• Injection, aprepitant, 1 mg (HCPCS:J0185)
• Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Blood test, comprehensive group of blood chemicals (HCPCS:80053)
• Injection, granisetron hydrochloride, 100 mcg (HCPCS:J1626)
• Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg (HCPCS:J1568)
• Injection of additional new drug or substance into vein (HCPCS:96375)
• Injection, iron dextran, 50 mg (HCPCS:J1750)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Injection, fluorouracil, 500 mg (HCPCS:J9190)
• Injection, pegfilgrastim-apgf, biosimilar, (nyvepria), 0.5 mg (HCPCS:Q5122)
• Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Iron level (HCPCS:83540)
• Iron binding capacity (HCPCS:83550)
• Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
• Ferritin (blood protein) level (HCPCS:82728)
• Magnesium level (HCPCS:83735)
• Flow cytometry technique for dna or cell analysis, each additional marker (HCPCS:88185)
• Phosphate level (HCPCS:84100)
• Cyclophosphamide, 100 mg (HCPCS:J9070)
• Injection, carboplatin, 50 mg (HCPCS:J9045)
• Injection, potassium chloride, per 2 meq (HCPCS:J3480)
• Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
• Gammaglobulin (immune system protein) measurement (HCPCS:82784)
• Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Oncology care model (ocm) monthly enhanced oncology services (meos) payment for ocm enhanced services. g9678 payments may only be made to ocm practitioners for ocm beneficiaries for the furnishment of enhanced services as defined in the ocm participation a (HCPCS:G9678)
• Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
• Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
• Unclassified drugs (HCPCS:J3490)
• Injection, zoledronic acid, 1 mg (HCPCS:J3489)
• Injection, magnesium sulfate, per 500 mg (HCPCS:J3475)
• Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
• Nephelometry, test method using light (HCPCS:83883)
• Lactate dehydrogenase (enzyme) level (HCPCS:83615)
• Injection, fosnetupitant 235 mg and palonosetron 0.25 mg (HCPCS:J1454)
• Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
• Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
• Injection, methylprednisolone sodium succinate, up to 125 mg (HCPCS:J2930)
• Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l (HCPCS:G0498)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Administration of additional new drug or substance into vein using push technique (HCPCS:96411)
• Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
• Folic acid level, serum (HCPCS:82746)
• Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
• Telephone medical discussion with physician, 5-10 minutes (HCPCS:99441)
• Protein measurement, serum (HCPCS:84165)
• Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
• Infusion into a vein for hydration, each additional hour (HCPCS:96361)
• Psa (prostate specific antigen) measurement, total (HCPCS:84153)
• Beta-2 microglobulin (protein) level (HCPCS:82232)
• Carcinoembryonic antigen (cea) protein level (HCPCS:82378)
• Automated urinalysis test (HCPCS:81003)
• Initial hospital inpatient care per day, typically 50 minutes (HCPCS:99222)
• Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
• Injection of drug or substance into vein (HCPCS:96374)
• Drawing of blood for a medical problem (HCPCS:99195)
• Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
• Blood test, clotting time (HCPCS:85610)
• Translocation analysis (bcr/abl1) major breakpoint (HCPCS:81206)
• Translocation analysis (bcr/abl1) minor breakpoint (HCPCS:81207)
• Immunologic analysis technique on serum (immunofixation) (HCPCS:86334)
• Vitamin d-3 level (HCPCS:82306)
• Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 (HCPCS:86300)
• Irrigation of implanted venous access drug delivery device (HCPCS:96523)
• Follow-up hospital inpatient care per day, typically 25 minutes (HCPCS:99232)
• New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
• Red blood cell sedimentation rate, to detect inflammation, automated (HCPCS:85652)
• Infusion, normal saline solution, sterile (500 ml = 1 unit) (HCPCS:J7040)
• Red blood count automated, with additional calculations (HCPCS:85046)
• Reticulated (young) platelet measurement (HCPCS:85055)
• Flow cytometry technique for dna or cell analysis, first marker (HCPCS:88184)
• Influenza vaccine, quadrivalent derived from cell cultures, preservative and antibiotic free (HCPCS:90674)
• Administration of influenza virus vaccine (HCPCS:G0008)
• Measurement c-reactive protein for detection of infection or inflammation (HCPCS:86140)

The enumeration date for this NPI number is 5/16/2006 and was last updated on 1/27/2023.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.